DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.06
Delayed Data
As of Feb 16
 -0.08 / -7.02%
Today’s Change
0.78
Today|||52-Week Range
5.20
-2.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2015

2016

2017
AssetsCash--1.8M6.2M6.6M
 
 
 
 
Short Term Investment Cash4.1M-3.0M4.4M428.8K
 
 
 
 
 
Cash & Short Term Investments4.1M1.8M6.2M6.6M
 
 
 
 
 
 
ReceivablesReceivables11.1K25.8K18.4K76.6K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses170.9K245.0K144.1K--
 
 
 
 
Other Current Assets0.000.000.001.2M
 
 
Current Assets4.3M2.0M6.3M7.9M
 
 
 
 
 
 
Total AssetsIntangible Assets0.000.0036.0K40.3K
 
 
 
Other Assets0.00550.1K36.0K40.3K
 
 
 
 
Total Assets4.3M2.6M6.4M7.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable140.5K0.000.001.3M
 
 
 
Accrued Expenses--762.3K584.0K--
 
 
 
Other Current Liabilities109.0K853.1K627.4K33.1K
 
 
 
 
 
Other Liabilities249.5K853.1K627.4K1.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt272.4K0.000.000.00
 
 
Other Liabilities4.6M2.5M869.6K28.1K
 
 
 
 
 
Total Liabilities5.1M3.4M1.5M1.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.00278.5K6.6M6.4M
 
 
 
 
Common Equity-818.0K-1.1M-1.7M153.1K
 
 
 
 
 
Total Shareholder Equity-818.0K-821.5K4.9M6.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding7.9M9.9M11.2M14.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.